Compare GSK plc (GSK) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Payoneer Global Inc — how do they compare? GSK plc trades at $52.81 (market cap $101.34B), while Payoneer Global Inc trades at $7.1 (market cap $2.40B). The key difference: GSK plc is far larger — about 42.2× Payoneer Global Inc's market cap, and GSK plc pays a 3.49% dividend while Payoneer Global Inc pays none. Which is the better fit depends on your goals.
| GSK | PAYO | |
|---|---|---|
Market Cap | $101.34B | $2.40B |
Sector | Health | Technology |
52-Week High | $61.18 | $7.42 |
52-Week Low | $36.20 | $4.27 |
Enterprise Value | $121.95B | $2.14B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global Inc. (PAYO) trades at $7.105, up 0.07% today, with a bullish technical signal from moving averages and a consensus analyst price target of $8.20. Recent news highlights its acquisition by Nuvei for $2.75 billion and expansion into India. Financially, revenue grew to $821.16M in 2025, though net income fell to $73.19M, and valuation ratios like P/E of 35.53 suggest premium pricing. The stock shows strong institutional interest but faces integration risks post-acquisition.
The outlook for PAYO is mixed; the Nuvei deal offers a near-term exit at $7.40 per share, but potential undervaluation concerns and shareholder lawsuits pose risks. Long-term growth hinges on successful integration and international expansion. Investors should weigh the acquisition premium against execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
